Skip to main content

Land & Buildings Issues White Paper Detailing Impact of Work From Home Trend On Life Science Office Market

Analysis Shows Employee Attendance in Life Science Buildings with a Combination of Laboratory and Office Space Down 50% Compared to Pre-Pandemic Levels – On Par With Traditional Office Buildings

Following an In-Depth Analysis of Alexandria Real Estate Equities’ Portfolio, Land & Buildings Predicts Shares Could See ~30-40% Downside From Current Levels

Land & Buildings Investment Management, LLC (together with its affiliates, “Land & Buildings”, “us” or “we”), today issued a white paper titled The Work From Home Hurricane Has Hit Life Science Offices, detailing the impact of COVID-19 on the life science office market. Specifically, Land & Buildings’ analysis focused on life science REIT company Alexandria Real Estate Equities, Inc. (NYSE: ARE).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230616782160/en/

With typically 50% laboratory space and 50% office space, many observers have considered companies with office exposure in the life science sector as a safe haven from the impact of the work-from-home phenomenon. Unfortunately, Land & Buildings’ analysis starkly contradicts this view. The full white paper can be found here.

Land & Buildings’ study concludes that if the path for life science follows traditional office, as it appears to be doing, Land & Buildings estimates ARE could trade at valuations similar to traditional coastal office REITs – which suggests an approximate 30-40% downside from current levels.

Previously, in May 2020, Land & Buildings published a white paper titled The New York Office Market is Facing an Existential Hurricane.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  209.77
-0.80 (-0.38%)
AAPL  255.92
+0.29 (0.11%)
AMD  217.50
+7.29 (3.47%)
BAC  49.38
+0.11 (0.22%)
GOOG  294.46
-0.44 (-0.15%)
META  574.46
-4.77 (-0.82%)
MSFT  373.46
+4.09 (1.11%)
NVDA  177.39
+1.64 (0.93%)
ORCL  146.38
+1.15 (0.79%)
TSLA  360.59
-20.67 (-5.42%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.